Ludger Ständker

发表

Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide

Uwe Albrecht, Frank Kirchhoff, Jan Münch, 2010, Science Translational Medicine.

Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide

Shibo Jiang, Thomas Peters, Bernd Meyer, 2007, Cell.

Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.

Thomas Braulke, T. Braulke, W. Forssmann, 2005, Biochemistry.

Exploiting natural peptide diversity: novel research tools and drug leads.

W. Forssmann, Wolf-Georg Forssmann, Knut Adermann, 2004, Current opinion in biotechnology.